Uterine immune test and personalized embryo transfer study
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at whether testing the immune cells in the uterus and then personalizing treatment improves the chance of success for patients who have a single embryo transfer. Eligible patients had the immune test and then a single blastocyst transfer within nine months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a uterine immune profiling test done.
- Within 9 months after that test, you received a single blastocyst embryo transfer (fresh or frozen) between January 2020 and June 2023.
- You did not skip the single embryo transfer step.
- Your transfer is matched to a control patient by age, fertility treatment history, and embryo development stage.
- You have not had a uterine immune profiling done more than 9 months before the transfer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This study compares different methods for transferring frozen embryos into the uterus during IVF. It aims to find the best technique to improve pregnancy chances.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This trial compares a new method to time a frozen embryo transfer (using a test called ERA) with the standard method. The goal is to find the best time to transfer a high-quality embryo in women who have had multiple failed IVF attempts (recurrent implantation failure).
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.